Pro-protein convertase subtilisin/kexin 9 concentrations correlate with coronary artery disease atheroma burden in a Pakistani cohort with chronic chest pain

Int J Clin Pract. 2015 Jul;69(7):738-42. doi: 10.1111/ijcp.12615. Epub 2015 Feb 24.

Abstract

Objective: To determine the relationship between proprotein convertase subtilisin kexin 9 (PCSK9) levels and atheroma burden in Pakistanis presenting to an ambulatory centre with chest pain.

Methods: A prospective matched case-control study of 400 patients selected for presence/absence of angiographic disease referred between 2001 and 2003. A comprehensive cardiovascular disease risk factor profile was assessed including demographics, environmental and biochemical risk factors including insulin resistance and PCSK-9 levels. Coronary atheroma burden was quantified by Gensini score.

Results: In this population, PCSK-9 levels were weakly correlated (r = 0.23) with male gender (p = 0.06) and number of diabetes years (p = 0.09), and inversely with log10 of lipoprotein (a) concentration (p = 0.07) but not LDL-C. In multiple regression analysis, Gensini score was associated with age (p = 0.002), established angina (p = 0.001), duration of diabetes (p = 0.05), low HDL-C (p < 0.001), lipoprotein (a) (p = 0.01), creatinine (p < 0.001), C-Reactive Protein (p = 0.02) and PSCK-9 (p = 0.05) concentrations. PCSK9 added to the regression model. Neither total cholesterol nor LDL-C were significant risk factors in this study.

Conclusions: Proprotein convertase subtilisin kexin 9 concentrations are correlated with atheroma burden in Indian Asian populations from the sub-continent, not taking statin therapy, independent of LDL-C or other CVD risk factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / blood
  • Case-Control Studies
  • Chest Pain / diagnosis
  • Chest Pain / etiology*
  • Chronic Pain / diagnosis
  • Chronic Pain / etiology*
  • Coronary Artery Disease / complications
  • Coronary Artery Disease / enzymology*
  • Coronary Artery Disease / epidemiology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Pakistan / epidemiology
  • Plaque, Atherosclerotic / complications
  • Plaque, Atherosclerotic / enzymology*
  • Plaque, Atherosclerotic / epidemiology
  • Prognosis
  • Proprotein Convertase 9 / blood*
  • Prospective Studies
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • Biomarkers
  • PCSK9 protein, human
  • Proprotein Convertase 9